Seikagaku Corporation (TYO:4548)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
LAL	12.15B	11.86B	10.27B	10.73B	9.16B
LAL Growth	2.46%	15.47%	-4.30%	17.23%	31.90%
Pharmaceutical Products and Related Goods	24.49B	-	-	-	-
Medical Products	-	27.51B	25.94B	22.72B	25.70B
Medical Products Growth	-	6.06%	14.17%	-11.57%	24.02%
Total	36.65B	39.37B	36.21B	33.46B	34.85B
Total Growth	-6.93%	8.73%	8.24%	-4.01%	25.99%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
North America	13.20B	16.22B	13.60B	13.20B	11.51B
North America Growth	-18.62%	19.22%	3.03%	14.70%	34.56%
Other Regions	9.42B	8.99B	8.51B	6.84B	6.41B
Other Regions Growth	4.80%	5.68%	24.31%	6.85%	24.01%
Japan	14.02B	14.16B	14.10B	13.41B	16.93B
Japan Growth	-1.00%	0.45%	5.17%	-20.82%	21.47%
Total	36.64B	39.37B	36.21B	33.46B	34.85B
Total Growth	-6.93%	8.73%	8.24%	-4.00%	25.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error